Biosimilar Newsletter Archive

  1. 04.16.20 -- Biosimilar Pipeline Sees 12 Percent Annual Growth 4/16/2020
    04/16/20 Biosimilar Development Newsletter
  2. 04.15.20 -- Outsourcing Models And Best Practices 4/15/2020
    04/15/20 Biosimilar Development Newsletter
  3. 04.10.20 -- Improve Process Development Efficiency And Outcomes 4/10/2020
    04/10/20 Biosimilar Development Newsletter
  4. 04.09.20 -- Biosimilars & Value-Based Care: What To Watch 4/9/2020
    04/09/20 Biosimilar Development Newsletter
  5. 04.02.20 -- Biosimilars In The Age Of Covid-19 4/2/2020
    04/02/20 Biosimilar Development Newsletter
  6. 03.26.20 -- 3 Biosimilar Questions Facing FDA, FTC, & Manufacturers 3/26/2020
    03/26/20 Biosimilar Development Newsletter
  7. 03.25.20 -- Modernizing Cell Therapy Manufacturing 3/25/2020
    03/25/20 Biosimilar Development Newsletter
  8. 03.19.20 -- How Can Hospitals Lead The Biosimilar Charge? 3/19/2020
    03/19/20 Biosimilar Development Newsletter
  9. 03.18.20 -- Uncover The Next Generation Of Immunotherapies 3/18/2020
    03/18/20 Biosimilar Development Newsletter
  10. 03.12.20 -- What Could Transform Biologics Reimbursement? 3/12/2020
    03/12/20 Biosimilar Development Newsletter